Reply to: Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status

Lindsay M. LaFave; Wendy Béguelin; Richard Koche; Matt Teater; Barbara Spitzer; Alan Chramiec; Efthymia Papalexi; Matthew D. Keller; Todd Hricik; Katerina Konstantinoff; Jean Baptiste Micol; Benjamin Durham; Sarah K. Knutson; John E. Campbell; Gil Blum; Xinxu Shi; Emma H. Doud; Andrei V. Krivtsov; Young Rock Chung; Inna Khodos; Elisa De Stanchina; Ouathek Ouerfelli; Prasad S. Adusumilli; Paul Martin Thomas; Neil L Kelleher; Minkui Luo; Heike Keilhack; Omar Abdel-Wahab; Ari Melnick; Scott A. Armstrong; Ross L. Levine

doi:10.1038/nm.4094

Reply to: Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status

Lindsay M. LaFave, Wendy Béguelin, Richard Koche, Matt Teater, Barbara Spitzer, Alan Chramiec, Efthymia Papalexi, Matthew D. Keller, Todd Hricik, Katerina Konstantinoff, Jean Baptiste Micol, Benjamin Durham, Sarah K. Knutson, John E. Campbell, Gil Blum, Xinxu Shi, Emma H. Doud, Andrei V. Krivtsov, Young Rock Chung, Inna KhodosElisa De Stanchina, Ouathek Ouerfelli, Prasad S. Adusumilli, Paul Martin Thomas, Neil L Kelleher, Minkui Luo, Heike Keilhack, Omar Abdel-Wahab, Ari Melnick, Scott A. Armstrong, Ross L. Levine^*

^*Corresponding author for this work

Research output: Contribution to journal › Letter

6 Scopus citations

Original language	English (US)
Pages (from-to)	578-579
Number of pages	2
Journal	Nature Medicine
Volume	22
Issue number	6
DOIs	https://doi.org/10.1038/nm.4094
State	Published - Jun 7 2016

ASJC Scopus subject areas

Biochemistry, Genetics and Molecular Biology(all)

Access to Document

10.1038/nm.4094

Cite this

LaFave, L. M., Béguelin, W., Koche, R., Teater, M., Spitzer, B., Chramiec, A., Papalexi, E., Keller, M. D., Hricik, T., Konstantinoff, K., Micol, J. B., Durham, B., Knutson, S. K., Campbell, J. E., Blum, G., Shi, X., Doud, E. H., Krivtsov, A. V., Chung, Y. R., ... Levine, R. L. (2016). Reply to: Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status. Nature Medicine, 22(6), 578-579. https://doi.org/10.1038/nm.4094

LaFave, Lindsay M. ; Béguelin, Wendy ; Koche, Richard ; Teater, Matt ; Spitzer, Barbara ; Chramiec, Alan ; Papalexi, Efthymia ; Keller, Matthew D. ; Hricik, Todd ; Konstantinoff, Katerina ; Micol, Jean Baptiste ; Durham, Benjamin ; Knutson, Sarah K. ; Campbell, John E. ; Blum, Gil ; Shi, Xinxu ; Doud, Emma H. ; Krivtsov, Andrei V. ; Chung, Young Rock ; Khodos, Inna ; De Stanchina, Elisa ; Ouerfelli, Ouathek ; Adusumilli, Prasad S. ; Thomas, Paul Martin ; Kelleher, Neil L ; Luo, Minkui ; Keilhack, Heike ; Abdel-Wahab, Omar ; Melnick, Ari ; Armstrong, Scott A. ; Levine, Ross L. / Reply to : Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status. In: Nature Medicine. 2016 ; Vol. 22, No. 6. pp. 578-579.

@article{8e66d236d154455f8ac9e4a43df4f8d8,

title = "Reply to: Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status",

author = "LaFave, {Lindsay M.} and Wendy B{\'e}guelin and Richard Koche and Matt Teater and Barbara Spitzer and Alan Chramiec and Efthymia Papalexi and Keller, {Matthew D.} and Todd Hricik and Katerina Konstantinoff and Micol, {Jean Baptiste} and Benjamin Durham and Knutson, {Sarah K.} and Campbell, {John E.} and Gil Blum and Xinxu Shi and Doud, {Emma H.} and Krivtsov, {Andrei V.} and Chung, {Young Rock} and Inna Khodos and {De Stanchina}, Elisa and Ouathek Ouerfelli and Adusumilli, {Prasad S.} and Thomas, {Paul Martin} and Kelleher, {Neil L} and Minkui Luo and Heike Keilhack and Omar Abdel-Wahab and Ari Melnick and Armstrong, {Scott A.} and Levine, {Ross L.}",

year = "2016",

month = jun,

day = "7",

doi = "10.1038/nm.4094",

language = "English (US)",

volume = "22",

pages = "578--579",

journal = "Nature Medicine",

issn = "1078-8956",

publisher = "Nature Publishing Group",

number = "6",

}

LaFave, LM, Béguelin, W, Koche, R, Teater, M, Spitzer, B, Chramiec, A, Papalexi, E, Keller, MD, Hricik, T, Konstantinoff, K, Micol, JB, Durham, B, Knutson, SK, Campbell, JE, Blum, G, Shi, X, Doud, EH, Krivtsov, AV, Chung, YR, Khodos, I, De Stanchina, E, Ouerfelli, O, Adusumilli, PS, Thomas, PM , Kelleher, NL, Luo, M, Keilhack, H, Abdel-Wahab, O, Melnick, A, Armstrong, SA & Levine, RL 2016, 'Reply to: Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status', Nature Medicine, vol. 22, no. 6, pp. 578-579. https://doi.org/10.1038/nm.4094

Reply to : Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status. / LaFave, Lindsay M.; Béguelin, Wendy; Koche, Richard; Teater, Matt; Spitzer, Barbara; Chramiec, Alan; Papalexi, Efthymia; Keller, Matthew D.; Hricik, Todd; Konstantinoff, Katerina; Micol, Jean Baptiste; Durham, Benjamin; Knutson, Sarah K.; Campbell, John E.; Blum, Gil; Shi, Xinxu; Doud, Emma H.; Krivtsov, Andrei V.; Chung, Young Rock; Khodos, Inna; De Stanchina, Elisa; Ouerfelli, Ouathek; Adusumilli, Prasad S.; Thomas, Paul Martin ; Kelleher, Neil L; Luo, Minkui; Keilhack, Heike; Abdel-Wahab, Omar; Melnick, Ari; Armstrong, Scott A.; Levine, Ross L.

In: Nature Medicine, Vol. 22, No. 6, 07.06.2016, p. 578-579.

Research output: Contribution to journal › Letter

TY - JOUR

T1 - Reply to

T2 - Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status

AU - LaFave, Lindsay M.

AU - Béguelin, Wendy

AU - Koche, Richard

AU - Teater, Matt

AU - Spitzer, Barbara

AU - Chramiec, Alan

AU - Papalexi, Efthymia

AU - Keller, Matthew D.

AU - Hricik, Todd

AU - Konstantinoff, Katerina

AU - Micol, Jean Baptiste

AU - Durham, Benjamin

AU - Knutson, Sarah K.

AU - Campbell, John E.

AU - Blum, Gil

AU - Shi, Xinxu

AU - Doud, Emma H.

AU - Krivtsov, Andrei V.

AU - Chung, Young Rock

AU - Khodos, Inna

AU - De Stanchina, Elisa

AU - Ouerfelli, Ouathek

AU - Adusumilli, Prasad S.

AU - Thomas, Paul Martin

AU - Kelleher, Neil L

AU - Luo, Minkui

AU - Keilhack, Heike

AU - Abdel-Wahab, Omar

AU - Melnick, Ari

AU - Armstrong, Scott A.

AU - Levine, Ross L.

PY - 2016/6/7

Y1 - 2016/6/7

UR - http://www.scopus.com/inward/record.url?scp=84976415504&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84976415504&partnerID=8YFLogxK

U2 - 10.1038/nm.4094

DO - 10.1038/nm.4094

M3 - Letter

C2 - 27270773

AN - SCOPUS:84976415504

VL - 22

SP - 578

EP - 579

JO - Nature Medicine

JF - Nature Medicine

SN - 1078-8956

IS - 6

ER -